Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TELA Bio Q2 2024 GAAP EPS $(0.51) Misses $(0.44) Estimate, Sales $16.091M Miss $18.460M Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:19pm
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.44) by 15.91 percent. This is a 10.87 percent decrease over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $16.091 million which missed the analyst consensus estimate of $18.460 million by 12.83 percent. This is a 11.02 percent increase over sales of $14.494 million the same period last year.

Posted In: TELA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist